Recent Updates
Recently added Catalysts
LIVN Positive Sentiment

LivaNova to Present at UBS, Wolfe, Stifel, and Jefferies Healthcare Conferences in November

Wednesday, October 21, 2026 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: LivaNova PLC announced that its Executive Leadership Team will present at four November healthcare conferences. The team will provide general business updates during fireside chats. Scheduled events include the UBS Global Healthcare Conference on November 9 and the Wolfe Research Healthcare Conference on November 10.

Market Sentiment Analysis

POSITIVE FACTORS

  • LivaNova is presenting at multiple prestigious healthcare conferences.
  • The company will provide business updates to stakeholders.
  • Engagement with investors and analysts is planned.

Full Press Release Details

GLOUCESTER, England--(BUSINESS WIRE)---- $LIVN #OSA--LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today announced that members of the Company’s Executive Leadership Team will provide general business updates during fireside chats at the four following November healthcare conferences: UBS Global Healthcare Conference on Mon., Nov. 9, from 11-11:35 a.m. EST in Palm Beach, Fla. 8th Annual Wolfe Research Healthcare Conference on Tues., Nov. 10, from 9:20-9:50 a.m. EST in New York City

Frequently Asked Questions

When will LivaNova present at the UBS conference?

LivaNova will present at the UBS Global Healthcare Conference on Nov. 9.

Who will provide updates during the conferences?

Members of LivaNova's Executive Leadership Team will provide updates.

What is the date of the Wolfe Research conference?

The Wolfe Research Healthcare Conference is on Nov. 10.

Where will the UBS conference take place?

The UBS Global Healthcare Conference will be in Palm Beach, Florida.

ShareAdd on Google
Tags: LIVN LivaNova healthcare conferences UBS Wolfe Research Executive Leadership Team
Last updated: Oct 21, 2026

Biotech snapshot

Cash runway
$517M liquidity · $0M/mo burn
Low dilution risk
Lead asset
REPLY 200Phase 3
Bradycardia →